Discovery and Validation of Nitroxoline as a Novel STAT3 Inhibitor in Drug-resistant Urothelial Bladder Cancer.
- Published in:
- International Journal of Biological Sciences, 2021, v. 17, n. 12, p. 3255, doi. 10.7150/ijbs.63125
- By:
- Publication type:
- Article